Caffeic Acid Acts as a Potent Senomorphic and Alleviates Inflammation and Lung Fibrosis by Covalently Targeting Annexin A5 Protein in Mice

Abstract

The accumulation of senescent cells and their secretion of senescence-associated secretory phenotype (SASP) play important roles in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Small molecules, known as senolytics or senomorphics, have been effective in targeting senescent cells. Although senolytic drugs have been well-studied in pulmonary fibrosis, senomorphics with defined protein targets and potential applications are rarely investigated. In this study, we identified a widely sourced natural product, caffeic acid (CA), to act as a potent senomorphic that effectively inhibits the secretion of SASP in senescent lung cells. We demonstrated that the covalent binding of CA to Annexin A5 protein triggered its degradation, PKCθ deactivation, and the inhibition of the NF-κB inflammatory pathway in senescent cells. Notably, CA exhibited a promising effect in limiting inflammation in the lung and circulatory system, alleviating pulmonary pathology, and improving physical function in a bleomycin-induced pulmonary fibrosis mouse model. Our investigation suggests that Annexin A5 could be used as the target for the precise intervention of aging-related diseases such as IPF.

Keywords

annexin A5 / caffeic acid / SASP / senescent cells / senomorphics

References

[1] F. J. Martinez, H. R. Collard, A. Pardo, et al., “Idiopathic Pulmonary Fibrosis,” Nature Reviews Disease primers3 (2017): 17074.

[2] T. M. Maher, “Interstitial Lung Disease,” JAMA331 (2024): 1655.

[3] D. J. Lederer and F. J. Martinez, “Idiopathic Pulmonary Fibrosis,” New England Journal of Medicine378 (2018): 1811-1823.

[4] M. J. Schafer, T. A. White, K. Iijima, et al., “Cellular Senescence Mediates Fibrotic Pulmonary Disease,” Nature Communications8 (2017): 14532.

[5] C. Yao, X. Guan, G. Carraro, et al., “Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis,” American Journal of Respiratory and Critical Care Medicine203 (2021): 707-717.

[6] P. J. Barnes, J. Baker, and L. E. Donnelly, “Cellular Senescence as a Mechanism and Target in Chronic Lung Diseases,” American Journal of Respiratory and Critical Care Medicine200 (2019): 556-564.

[7] J. Chang, Y. Wang, L. Shao, et al., “Clearance of Senescent Cells by ABT263 Rejuvenates Aged Hematopoietic Stem Cells in Mice,” Nature Medicine22 (2016): 78-83.

[8] L. J. Niedernhofer and P. D. Robbins, “Senotherapeutics for Healthy Ageing,” Nature Reviews Drug Discovery17 (2018): 377-377.

[9] Y. Zhu, T. Tchkonia, H. Fuhrmann-Stroissnigg, et al., “Identification of a Novel Senolytic Agent, Navitoclax, Targeting the BCL-2 Family of Anti-Apoptotic Factors,” Aging Cell15 (2016): 428-435.

[10] Y. Zhu, T. Tchkonia, T. Pirtskhalava, et al., “The Achilles' Heel of Senescent Cells: From Transcriptome to Senolytic Drugs,” Aging Cell14 (2015): 644-658.

[11] J. C. Cooley, N. Javkhlan, J. A. Wilson, et al., “Inhibition of Antiapoptotic BCL-2 Proteins With ABT-263 Induces Fibroblast Apoptosis, Reversing Persistent Pulmonary Fibrosis,” JCI Insight8 (2023): e163762.

[12] J. N. Justice, A. M. Nambiar, T. Tchkonia, et al., “Senolytics in Idiopathic Pulmonary Fibrosis: Results From a First-in-Human, Open-Label, Pilot Study,” EBioMedicine40 (2019): 554-563.

[13] A. Nambiar, D. Kellogg, J. Justice, et al., “Senolytics Dasatinib and Quercetin in Idiopathic Pulmonary Fibrosis: Results of a Phase I, Single-Blind, Single-Center, Randomized, Placebo-Controlled Pilot Trial on Feasibility and Tolerability,” EBioMedicine90 (2023): 104481.

[14] Y. Zhang, Q. Zhang, Z. Chu, et al., “Oridonin Acts as a Novel Senolytic by Targeting Glutathione S-Transferases to Activate the ROS-p38 Signaling Axis in Senescent Cells,” Chemical Communications (Cambridge, England)58 (2022): 13250-13253.

[15] S. Mirzaei, M. H. Gholami, A. Zabolian, et al., “Caffeic Acid and Its Derivatives as Potential Modulators of Oncogenic Molecular Pathways: New Hope in the Fight Against Cancer,” Pharmacological Research171 (2021): 105759.

[16] N. N. Muhammad Abdul Kadar, F. Ahmad, S. L. Teoh, and M. F. Yahaya, “Caffeic Acid on Metabolic Syndrome: A Review,” Molecules (Basel, Switzerland)26 (2021): 5490.

[17] K. M. M. Espíndola, R. G. Ferreira, L. E. M. Narvaez, et al., “Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma,” Frontiers in Oncology9 (2019): 541.

[18] Y. Zhu, Y. Zhang, Q. Zhang, et al., “Gambogic Acid Suppresses the Pentose Phosphate Pathway by Covalently Inhibiting 6PGD Protein in Cancer Cells,” Chemical Communications (Cambridge, England)58 (2022): 9030-9033.

[19] M. Kuljanin, D. C. Mitchell, D. K. Schweppe, et al., “Reimagining High-Throughput Profiling of Reactive Cysteines for Cell-Based Screening of Large Electrophile Libraries,” Nature Biotechnology39 (2021): 630-641.

[20] Y. Zhu, L. Wang, J. Li, et al., “Photoaffinity Labeling Coupled With Proteomics Identify PDI-ADAM17 Module is Targeted by (−)-Vinigrol to Induce TNFR1 Shedding and Ameliorate Rheumatoid Arthritis in Mice,” Cell Chemical Biology31 (2024): 452-464.e10.

[21] T. H. Kang, J. H. Park, A. Yang, et al., “Annexin A5 as an Immune Checkpoint Inhibitor and Tumor-Homing Molecule for Cancer Treatment,” Nature Communications11 (2020): 1137.

[22] K. Klement, C. Melle, U. Murzik, S. Diekmann, J. Norgauer, and P. Hemmerich, “Accumulation of Annexin A5 at the Nuclear Envelope is a Biomarker of Cellular Aging,” Mechanisms of Ageing and Development133 (2012): 508-522.

[23] A. K. Hurben, L. N. Erber, N. Y. Tretyakova, and T. M. Doran, “Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine,” Acs Chemical Biology16 (2021): 2581-2594.

[24] I. Dikic, “Proteasomal and Autophagic Degradation Systems,” Annual Review of Biochemistry86 (2017): 193-224.

[25] G. V. Semisotnov, N. A. Rodionova, O. I. Razgulyaev, V. N. Uversky, A. F. Gripas', and R. I. Gilmanshin, “Study of the “Molten Globule” Intermediate State in Protein Folding by a Hydrophobic Fluorescent Probe,” Biopolymers31 (1991): 119-128.

[26] Z. Hu, L. Li, B. Zhu, et al., “Annexin A5 is Essential for PKCθ Translocation During T-Cell Activation,” Journal of Biological Chemistry295 (2020): 14214-14221.

[27] A. Salminen, A. Kauppinen, and K. Kaarniranta, “Emerging Role of NF-κB Signaling in the Induction of Senescence-Associated Secretory Phenotype (SASP),” Cell Signalling24 (2012): 835-845.

[28] Y. Cai, H. Zhou, Y. Zhu, et al., “Elimination of Senescent Cells by β-Galactosidase-Targeted Prodrug Attenuates Inflammation and Restores Physical Function in Aged Mice,” Cell Research30 (2020): 574-589.

[29] V. D. Longo and R. M. Anderson, “Nutrition, Longevity and Disease: From Molecular Mechanisms to Interventions,” Cell185 (2022): 1455-1470.

[30] C. Luís, A. T. Maduro, P. Pereira, J. J. Mendes, R. Soares, and R. Ramalho, “Nutritional Senolytics and Senomorphics: Implications to Immune Cells Metabolism and Aging—From Theory to Practice,” Frontiers in Nutrition9 (2022): 958563.

[31] S. M. Lagoumtzi and N. Chondrogianni, “Senolytics and Senomorphics: Natural and Synthetic Therapeutics in the Treatment of Aging and Chronic Diseases,” Free Radical Biology and Medicine171 (2021): 169-190.

[32] A. Larki, A. A. Hemmati, A. Arzi, M. G. Borujerdnia, S. Esmaeilzadeh, and M. R. Zad Karami, “Regulatory Effect of Caffeic Acid Phenethyl Ester on Type I Collagen and Interferon-Gamma in Bleomycin-Induced Pulmonary Fibrosis in Rat,” Research in Pharmaceutical Sciences8 (2013): 243-252.

[33] A. Larki-Harchegani, A. A. Hemmati, A. Arzi, et al., “Evaluation of the Effects of Caffeic Acid Phenethyl Ester on Prostaglandin E2 and Two Key Cytokines Involved in Bleomycin-Induced Pulmonary Fibrosis,” Iranian Journal of Basic Medical Sciences16 (2013): 850-857.

[34] H. Özyurt, S. Söğüt, Z. Yıldırım, et al., “Inhibitory Effect of Caffeic Acid Phenethyl Ester on Bleomycine-Induced Lung Fibrosis in Rats,” Clinica Chimica Acta339 (2004): 65-75.

[35] S. Buckley, W. Shi, W. Xu, et al., “Increased Alveolar Soluble Annexin V Promotes Lung Inflammation and Fibrosis,” European Respiratory Journal46 (2015): 1417-1429.

[36] C. Luo, X. Ji, J. Fan, et al., “Annexin A5 Promotes Macrophage Activation and Contributes to Pulmonary Fibrosis Induced by Silica Particles,” Toxicology and Industrial Health32 (2016): 1628-1638.

RIGHTS & PERMISSIONS

2025 The Author(s). Exploration published by Henan University and John Wiley & Sons Australia, Ltd.